Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)
Clinical trial NCT05417789 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05417789
- Sponsor
- SynOx Therapeutics Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-09
- Primary completion
- 2025-12-23
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.